Table 3.

Recommendations for systemic thrombolysis in neonates and children.

Contraindications
Strong within 10 days after hemorrhage or major surgery 
 within 7 days after severe asphyxia 
 within 3 days after invasive procedure 
Soft within 48 hours after cerebral convulsion 
 prematurity < 32 weeks of gestation 
 sepsis 
 active minor hemorrhage 
 refractory thrombcytopenia and hypofibrinogenemia 
Contraindications
Strong within 10 days after hemorrhage or major surgery 
 within 7 days after severe asphyxia 
 within 3 days after invasive procedure 
Soft within 48 hours after cerebral convulsion 
 prematurity < 32 weeks of gestation 
 sepsis 
 active minor hemorrhage 
 refractory thrombcytopenia and hypofibrinogenemia 
TherapyLoading DoseMaintenanceMonitoring
Indications: extensive and/or life/organ-threatening thrombosis. Contraindications: on an individual basis to be considered relative, not absolute; keep fibrinogen > 0.5 g/L and platelets > 50 g/L; increasing D-dimers indicate effective fibrinolysis; dose reduction or cessation of rt-PA if major bleeding occurs; minor bleeding (oozing from catheter puncture site or wound) treat with local pressure; optimal duration of rt-PA therapy uncertain, mostly up to 7 days, shorter/longer courses 
rt-PA 0.1–0.2 mg/kg/10 min. 0.8–2.4 mg/kg/24 h FI, platelets, D-dimers 
UFH none 5–10 U/kg/h Apt 
TherapyLoading DoseMaintenanceMonitoring
Indications: extensive and/or life/organ-threatening thrombosis. Contraindications: on an individual basis to be considered relative, not absolute; keep fibrinogen > 0.5 g/L and platelets > 50 g/L; increasing D-dimers indicate effective fibrinolysis; dose reduction or cessation of rt-PA if major bleeding occurs; minor bleeding (oozing from catheter puncture site or wound) treat with local pressure; optimal duration of rt-PA therapy uncertain, mostly up to 7 days, shorter/longer courses 
rt-PA 0.1–0.2 mg/kg/10 min. 0.8–2.4 mg/kg/24 h FI, platelets, D-dimers 
UFH none 5–10 U/kg/h Apt 

or Create an Account

Close Modal
Close Modal